Corient Capital Partners’s Moody's MCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.14M Buy
7,865
+191
+2% +$55.5K 0.16% 118
2022
Q2
$2.09M Sell
7,674
-436
-5% -$130K 0.16% 127
2022
Q1
$2.74M Buy
8,110
+909
+13% +$306K 0.18% 120
2021
Q4
$2.81M Buy
7,201
+54
+0.8% +$20.8K 0.19% 120
2021
Q3
$2.54M Sell
7,147
-216
-3% -$81.4K 0.19% 120
2021
Q2
$2.67M Sell
7,363
-70
-0.9% -$23.3K 0.19% 110
2021
Q1
$2.22M Buy
7,433
+232
+3% +$65.3K 0.19% 110
2020
Q4
$2.09M Sell
7,201
-647
-8% -$181K 0.21% 105
2020
Q3
$2.27M Sell
7,848
-178
-2% -$50.8K 0.26% 89
2020
Q2
$2.21M Buy
8,026
+1,994
+33% +$507K 0.27% 87
2020
Q1
$1.27M Buy
6,032
+2,136
+55% +$519K 0.2% 106
2019
Q4
$925K Buy
3,896
+149
+4% +$33.1K 0.12% 185
2019
Q3
$767K Buy
3,747
+1,501
+67% +$315K 0.11% 199
2019
Q2
$439K Buy
2,246
+141
+7% +$26.8K 0.07% 259
2019
Q1
$381K Buy
+2,105
New +$346K 0.06% 253

Other funds holding MCO

Corient Capital Partners's MCO Position: Q3 2022 in Review

Corient Capital Partners increased its Moody's (MCO) stake by 2.5% in Q3 2022, buying an estimated $55.5K and bringing the position to 7,865 shares worth $2.14M. The position accounts for 0.16% of the portfolio, ranked #118.

Corient Capital Partners first reported a position in MCO in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.81M in Q4 2021. 933 funds tracked by Wall St. Rank hold MCO as of Q3 2022.

  • Corient Capital Partners held 7,865 shares of Moody's worth $2.14M as of Q3 2022.
  • Corient Capital Partners bought 191 Moody's shares in Q3 2022, an estimated $55.5K.
  • Moody's made up 0.16% of Corient Capital Partners's portfolio in Q3 2022, its #118 holding.
  • Corient Capital Partners first reported a position in Moody's in Q1 2019 and has held it in 15 quarters since.
  • Corient Capital Partners's Moody's position peaked at $2.81M in Q4 2021.
  • 933 funds tracked by Wall St. Rank held Moody's as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.